Trial intelligence / Profile preview

APD515 for Xerostomia in Advanced Cancer

NCT01331746Phase 2Completed

Sponsor
Acacia Pharma Group Plc
Start
Sep 2011
Primary completion
Dec 2012
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of bethanechol in xerostomia, sponsored by Acacia Pharma Group Plc. Started Sep 2011; status: completed.

02

Drugs

bethanechol
03

Conditions

xerostomia

Beyond the preview

Go deeper on NCT01331746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01331746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call